Market Place
Sourcing Support
Innoviva to Participate in the UBS Global Healthcare Conference
12 Nov 2024 //
BUSINESSWIRE
Innoviva Reports Q3 2024 Results & Company Progress
06 Nov 2024 //
BUSINESSWIRE
Innoviva Presents New Clinical Data From Its Pipeline At IDWeek 2024
15 Oct 2024 //
BUSINESSWIRE
Innoviva to Participate in Upcoming Investor Conferences
04 Sep 2024 //
BUSINESSWIRE
Innoviva Reports Q2 2024 Results And Company Progress
31 Jul 2024 //
BUSINESSWIRE
Innoviva To Participate In Goldman Sachs Healthcare Conference
03 Jun 2024 //
BUSINESSWIRE
Zai Lab, Innoviva`s SUL-DUR Approved In China For Pneumonia
20 May 2024 //
BUSINESSWIRE
Innoviva to Participate in the BofA Securities Health Care Conference
08 May 2024 //
BUSINESSWIRE
Innoviva: Q1 2024 Financials, Recent Progress
08 May 2024 //
BUSINESSWIRE
Innoviva`s Zoliflodacin Gonorrhea Phase 3 Data at ESCMID
24 Apr 2024 //
BUSINESSWIRE
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results
29 Feb 2024 //
BUSINESSWIRE
Results Announced in Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic
01 Nov 2023 //
BUSINESSWIRE
Innoviva Reports Third Quarter 2023 Financial Results
01 Nov 2023 //
BUSINESSWIRE
Innoviva Specialty Presents Data on Critical Care Antibiotic Therapy Portfolio
11 Oct 2023 //
BUSINESSWIRE
Innoviva to Participate in the Cantor Global Healthcare Conference
19 Sep 2023 //
BUSINESSWIRE
XACDURO Now Available to Treat HABP
18 Sep 2023 //
BUSINESSWIRE
Innoviva Appoints Stephen Basso as Chief Financial Officer
25 Aug 2023 //
BUSINESSWIRE
Innoviva Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
BUSINESSWIRE
FDA signs off on Innoviva`s Xacduro for bacterial pneumonia
24 May 2023 //
FIERCE PHARMA
Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO
23 May 2023 //
BUSINESSWIRE
Results from Phase 3 ATTACK Trial Published in The Lancet Infectious Diseases
11 May 2023 //
BUSINESSWIRE
Innoviva Reports1Q 2023 FYR and Highlights Recent Company Progress
09 May 2023 //
BUSINESSWIRE
Innoviva Announces Retirement of Board Chairman
28 Apr 2023 //
BUSINESSWIRE
FDA panel backs Innoviva`s drug for multidrug-resistant bacterial infections
18 Apr 2023 //
REUTERS
Innoviva Stock Trading Halted Today
17 Apr 2023 //
BUSINESSWIRE
Innoviva Announces FDA Advisory Committee Meeting to Review SUL-DUR
13 Mar 2023 //
BUSINESSWIRE
Innoviva Reports Fourth Quarter 2022 Financial Results
28 Feb 2023 //
BUSINESSWIRE
Innoviva Announces FDA Acceptance and Priority Review of NDA for (SUL-DUR)
30 Nov 2022 //
BUSINESSWIRE
Innoviva Reports 3Q 2022 Financial Results &Highlights Recent Company Progress
09 Nov 2022 //
BUSINESSWIRE
Entasis Presents Safety Data from Landmark PIII ATTACK Trial at IDWEEK 2022
19 Oct 2022 //
GLOBENEWSWIRE
La Jolla Announces Data on XERAVA to be Presented at IDWeek 2022
14 Oct 2022 //
BUSINESSWIRE
Entasis , a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR
12 Oct 2022 //
GLOBENEWSWIRE
Innoviva to Participate in the Morgan Stanley Global Healthcare Conference
08 Sep 2022 //
BUSINESSWIRE
Innoviva Completes Acquisition of La Jolla Pharmaceutical
22 Aug 2022 //
BUSINESSWIRE
Innoviva Reports Second Quarter 2022 Financial Results
27 Jul 2022 //
BUSINESSWIRE
Innoviva Sells 15% Stake in Theravance Respiratory Co. to Royalty Pharma
13 Jul 2022 //
BUSINESSWIRE
Innoviva to Acquire La Jolla Pharmaceutical Company
11 Jul 2022 //
BUSINESSWIRE
Innoviva Completes Acquisition of Entasis Therapeutics
11 Jul 2022 //
BUSINESSWIRE
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Tx
08 Jul 2022 //
BUSINESSWIRE
Innoviva to acquire Entasis Therapeutics for $2.20/share
24 May 2022 //
SEEKING ALPHA
Innoviva Reports First Quarter 2022 Financial Results
27 Apr 2022 //
BUSINESSWIRE
Innoviva Reports Fourth Quarter 2021 Financial Results
09 Feb 2022 //
BUSINESSWIRE
Entasis Therapeutics Receives Acquisition Proposal from Existing Majority Stockholder Innoviva Inc.
02 Feb 2022 //
PRESS RELEASE
Innoviva Reports Second Quarter 2021 Financial Results
29 Jul 2021 //
BUSINESSWIRE
GSK dumps entire stake in respiratory treatment partner Innoviva
21 May 2021 //
FIERCEPHARMA
Innoviva Reports Fourth Quarter 2020 Financial Results
03 Feb 2021 //
BUSINESSWIRE
Innoviva Reports Fourth Quarter 2020 Financial Results
03 Feb 2021 //
BUSINESSWIRE
